MEMPHIS, Tenn. & TORONTO--(BUSINESS WIRE)--State & Federal Compliance requirements are an ongoing challenge for EMS Agencies today, especially the evolving requirements related to narcotic storage and record keeping. BioConnect has designed the MedixSafe Retrofit Fit solution to help with the financial and operational challenge of aging infrastructure in the face of increasing stringent compliance requirements to continue as a licensed provider of controlled substances.
BioConnection, an independent CMO based in Oss, The Netherlands, specialized in the production of sterile drug products for medicinal use in humans, has been granted GMP Certification by the Dutch Healthcare and Youth Inspectorate (IGJ) for the production of sterile drug products on their new large scale filling line. The granting of this production license means that BioConnection now can produce sterile medicines in their facility for its customers on a much larger scale than before. The company is now also well positioned to fill a gap in the worldwide shortage in fill & finish production capacity for, amongst others, vaccines.